Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Inovio Pharmaceuticals, Inc.
INOVIO to Participate in Upcoming Scientific and Investor Conferences
May 28, 2026
INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 26, 2026
INOVIO to Participate in Upcoming Scientific Conferences
May 25, 2026
INOVIO to Report First Quarter Financial Results on May 13, 2026
May 24, 2026
Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO’s Partner in China
May 23, 2026
INOVIO Announces Pricing of $17.5 Million Public Offering
May 20, 2026
INOVIO Announces Proposed Public Offering
May 20, 2026
INOVIO to Participate in Upcoming Scientific Conference
May 20, 2026
INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
May 16, 2026
FDA Accepts for Review INOVIO’s BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
December 29, 2025
1
2
Next Page
→